Innovation Medical(002173) 证券时报网·2025-04-24 07:07Core Viewpoint - The company emphasizes the importance of innovation in the medical service industry, particularly in response to changes in medical insurance policies that affect profitability and operational efficiency [1][2]. Group 1: Company Operations - The company has experienced a decline in medical service gross margins due to adjustments in medical insurance settlement policies, despite an increase in outpatient and inpatient volumes [2]. - The company operates four hospitals: Jianhua Hospital, Kanghua Hospital, Futian Hospital, and Mingzhu Hospital, which are actively making adjustments to cope with market changes [2]. - The company is focusing on enhancing the quality and efficiency of its hospitals while investing in emerging medical technologies such as brain-computer interface (BCI) and AI medical models [2][4]. Group 2: AI Medical Model Development - The AI medical model developed by the company's affiliate, Quanzhen Medical, has demonstrated capabilities in providing diagnostic suggestions and generating medical records, significantly improving doctor efficiency and service quality [3]. - In 2024, Quanzhen Medical anticipates generating revenue of 4.4 million yuan from its AI medical model, with a target of 40 million yuan in 2025 [3]. - The company plans to expand its partnerships with hospitals, aiming to increase the number of collaborations from approximately 60 to 160 in the near future [3]. Group 3: Brain-Computer Interface (BCI) Project - The BCI project has developed a product line that includes systems for rehabilitation training and neuro-signal acquisition, with clinical trials already underway in several hospitals [4]. - The BCI products are expected to complete regulatory registration by mid-2026, with consumer products entering mass production and anticipated market launch in 2025 [4]. Group 4: Future Development Strategy - The company aims to enhance hospital operational capabilities and efficiency while actively exploring the commercialization of advanced medical technologies [5]. - The focus will be on capital operations that align with the company's strategic direction and investment value, leveraging technological advancements to improve the medical service industry [5].